查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1927377

按包裝類型、溫度範圍、隔熱材料、運輸方式和最終用戶分類的醫藥溫控包裝解決方案市場—2026-2032年全球預測

Pharmaceuticals Temperature Controlled Packaging Solutions Market by Packaging Type, Temperature Range, Insulation Material, Shipping Mode, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫藥溫控包裝解決方案市場規模將達到 149.1 億美元，到 2026 年將成長至 159.6 億美元，到 2032 年將達到 241.9 億美元，複合年成長率為 7.15%。

關鍵市場統計數據
基準年 2025 149.1億美元
預計年份：2026年 159.6億美元
預測年份 2032 241.9億美元
複合年成長率 (%) 7.15%

將溫控包裝在製藥業中不斷演變的角色定位為產品完整性、永續性和供應鏈韌性的策略性推動因素

醫藥低溫運輸環境要求包裝解決方案既能保護產品完整性，又能滿足不斷變化的監管、物流和商業要求。生物製藥、細胞和基因療法以及溫度敏感型小分子藥物的進步，日益增加了分銷的複雜性，迫使相關人員重新評估臨床和商業生命週期中的包裝策略。隨著產品有效載荷的日益多樣化，包裝必須在嚴格的熱性能、成本、永續性和操作實用性之間取得平衡。

了解近期技術進步和分銷模式的轉變如何從根本上重塑藥品溫控包裝策略和採購決策。

近年來，醫藥供應鏈中溫控包裝的概念、採購和運作方式發生了變革性轉變。主動冷卻系統的創新延長了低溫運輸的有效持續時間，從而實現了更長的運輸時間和更大的路線柔軟性。同時，被動系統（先進相變材料和真空絕熱板）的創新在提高性能的同時，降低了有效載荷的重量和體積。總而言之，這些技術進步顯著改變了成本、風險和碳足跡之間的權衡關係。

評估近期美國關稅調整對藥品溫控包裝的採購、設計和物流策略的廣泛而複雜的影響

2025年美國關稅政策的發展將對醫藥供應鏈中溫控包裝的成本結構和籌資策略產生累積影響。原料和成品組件的關稅調整將增加到岸成本並加劇價格波動，迫使採購團隊重新評估供應商組成和總到岸成本的計算。為此，許多企業正在增加供應商多元化和近岸外包的力度，以降低關稅引發的價格波動風險，同時維持服務水準。

從包裝類型、溫度範圍到隔熱材料、運輸方式和最終用戶需求等不同的細分維度，如何導致差異化的包裝策略和採購決策。

細分市場層面的趨勢揭示了不同的性能和應用模式，相關人員在選擇溫控包裝時應考慮這些因素。按包裝類型評估，主動式和被動式解決方案相輔相成。主動式解決方案，例如乾冰系統和冷媒盒，非常適合需要持續低溫和長途運輸的貨物。而被動式解決方案，無論是可重複使用或一次性使用，通常都能在短距離運輸中最佳化操作簡便性、降低初始成本並減少搬運風險。

全球市場在基礎設施、法規和供應鏈成熟度方面的區域差異正在影響溫控包裝的採用模式和策略重點。

區域趨勢既影響特定技術的可用性，也影響影響包裝選擇的物流限制。在美洲，對溫控治療藥物和先進物流基礎設施日益成長的需求，推動了遙測包裝和可重複使用系統的廣泛應用，這些系統可以整合到現有的低溫運輸網路中。隨著分銷範圍的擴大，擴充性、合規性和最後一公里可靠性在這裡變得至關重要。

供應商創新、跨產業夥伴關係以及「即服務」經營模式將如何重塑競爭格局並加速整合溫控包裝解決方案的普及應用？

主要企業之間競爭與合作的動態關係正在重新定義包裝解決方案的設計、檢驗和上市方式。領先的供應商正投資於整合熱工程、遙測技術和生命週期服務模式的綜合解決方案，為製藥客戶提供承包解決方案。這一趨勢正在促進包裝專家、材料創新者和物流供應商之間的夥伴關係，以確保端到端的無縫性能和責任落實。

為採購、品質和物流領導者提供切實可行的策略行動，以增強韌性、降低擁有成本並與監管和永續性優先事項保持一致。

產業領導者可以採取多項切實可行的措施來提高韌性、降低整體擁有成本並實現監管和永續性目標。首先，在藥物研發早期就應將包裝決策納入考量，使熱保護要求與有效載荷敏感性、劑型和商業分銷策略保持一致。儘早進行調整可以減少重新設計週期，並加快產品上市速度，同時確保供應鏈合作夥伴能夠在規模化生產之前檢驗流程。

調查方法概述：本研究採用混合方法，結合一手訪談、技術檢驗和監管整合，為企業決策者提供實用見解。

本報告採用混合研究途徑，結合了訪談、技術檢驗以及對已發布的監管指南和標準的系統性回顧。主要資料來源包括對供應鏈負責人、包裝工程師、臨床物流經理和高級採購人員的結構化訪談，以便能夠對實務經驗、挑戰和創新重點進行三角驗證。這些第一手觀點被用於情境分析，並評估不同溫度曲線和運輸方式下的設計權衡。

總之，我們強調，有必要將溫控包裝納入端到端的產品生命週期規劃中，以保護價值並確保連續性。

高效的溫控包裝如今在藥品完整性、法規遵循性和商業性分銷方面發揮核心作用。主動式和被動式系統的技術進步，以及對可追溯性和永續性嚴格的要求，已使包裝成為貫穿研發、臨床和商業供應鏈的策略性考量。因此，決策者在選擇解決方案時必須權衡熱性能、操作可行性和環境影響。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依包裝類型分類的藥品溫控包裝解決方案市場

  • 活性解決方案
    • 乾冰系統
    • 冷媒盒
  • 被動解決方案
    • 可重複使用的
    • 一次性

9. 依溫度範圍分類的藥品溫控包裝解決方案市場

  • 冷藏溫度
  • 管制室溫
  • 冰凍溫度

第10章：以隔熱材料分類的醫藥溫控包裝解決方案市場

  • 發泡聚苯乙烯
  • 相變材料
    • 共晶溶液
    • 無機物
    • 有機的
  • 真空絕熱板

第11章：以運輸方式分類的藥品溫控包裝解決方案市場

  • 空運貨物
  • 陸運
    • 鐵路運輸
    • 道路運輸
  • 海上運輸

第12章：以最終用戶分類的醫藥溫控包裝解決方案市場

  • 臨床研究所
    • 第一、二期設施
    • 三期至四期設施
  • 批發商
  • 製藥公司
  • 連鎖藥局

第13章：按地區分類的醫藥溫控包裝解決方案市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：依組別分類的藥品溫控包裝解決方案市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國醫藥溫控包裝解決方案市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國藥品溫控包裝解決方案市場

第17章：中國醫藥溫控包裝解決方案市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Berry Global, Inc.
  • Cold Chain Technologies, Inc.
  • Cryopak, Inc.
  • Envirotainer AB
  • Pelican Products, Inc.
  • Polar Tech Industries, LLC
  • Sealed Air
  • Softbox Systems Ltd.
  • Sonoco Products Company
  • Thermo Fisher Scientific, Inc.
  • va-Q-tec AG
Product Code: MRR-4F7A6D4FF385

The Pharmaceuticals Temperature Controlled Packaging Solutions Market was valued at USD 14.91 billion in 2025 and is projected to grow to USD 15.96 billion in 2026, with a CAGR of 7.15%, reaching USD 24.19 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 14.91 billion
Estimated Year [2026] USD 15.96 billion
Forecast Year [2032] USD 24.19 billion
CAGR (%) 7.15%

Framing the evolving role of temperature-controlled packaging in pharmaceuticals as a strategic enabler for product integrity, sustainability, and supply chain resilience

The pharmaceutical cold chain environment demands packaging solutions that protect product integrity while aligning with evolving regulatory, logistical, and commercial requirements. Advances in biologics, cell and gene therapies, and temperature-sensitive small molecules have increased the complexity of distribution, prompting stakeholders to reassess packaging strategies across clinical and commercial lifecycles. As product payloads diversify, packaging must reconcile strict thermal performance with cost, sustainability, and operational practicality.

Effective introduction requires an appreciation of the multiple interdependent pressures shaping the category. Regulatory scrutiny of temperature excursions, the growth of decentralized clinical trials, and the push for lower carbon logistics have converged to elevate packaging from a tactical commodity to a strategic enabler. Consequently, procurement, quality, and logistics leaders now collaborate earlier in product development to specify solutions that balance thermal protection, handling ergonomics, and end-to-end visibility.

Understanding how recent technological advances and shifting distribution models are fundamentally reshaping pharmaceutical temperature-controlled packaging strategies and procurement decisions

Recent years have produced transformative shifts in how temperature-controlled packaging is conceptualized, procured, and operated across pharmaceutical supply chains. Technological innovation in active cooling systems has expanded viable cold-chain windows, enabling longer shipments and more flexible routing. At the same time, innovations in passive systems-advanced phase change materials and vacuum insulated panels-have improved performance while reducing payload weight and volume. These technology advances, when taken together, have materially altered tradeoffs between cost, risk, and carbon footprint.

Concurrently, market dynamics such as the decentralization of clinical trials and the rapid increase in direct-to-patient deliveries have reshaped demand profiles. Logistics providers are optimizing modal mixes and last-mile capabilities to accommodate smaller, more frequent shipments. In parallel, regulatory expectations for chain-of-custody documentation and real-time temperature monitoring have raised the bar for packaging that integrates telemetry and tamper-evident features. Together, these developments are pushing stakeholders to adopt modular, scalable solutions that can be tailored to diverse product temperature profiles and shipment scenarios.

Evaluating the broad and compounding effects of recent United States tariff adjustments on sourcing, design, and logistical strategies for pharmaceutical temperature-controlled packaging

United States tariff policy developments in 2025 have cumulative implications for the cost structure and sourcing strategies of temperature-controlled packaging within pharmaceutical supply chains. Tariff adjustments on raw materials and finished components increase landed costs and introduce price volatility, prompting procurement teams to reassess supplier footprints and total landed cost calculations. In response, many organizations intensify supplier diversification and nearshoring efforts to mitigate exposure to tariff-driven price swings while preserving service levels.

Moreover, tariffs incentivize re-evaluation of material choices and design decisions. For instance, increased import costs for certain insulation substrates or active system components can accelerate substitution toward locally produced alternatives or recycled feedstocks where technical performance permits. Simultaneously, logistics strategies adapt: longer domestic transit routes may become more attractive relative to cross-border shipments subject to tariff differentials, and carriers and packagers collaborate to redesign packaging to reduce weight and dimensional profiles. Overall, these shifts cultivate a more regionally optimized supply base and elevate strategic sourcing as a critical lever for cost control and continuity of supply.

How distinct segmentation dimensions-from packaging type and temperature range to insulation material, shipping mode, and end-user requirements-drive differentiated packaging strategies and procurement decisions

Segment-level dynamics reveal distinct performance and adoption patterns that industry stakeholders must consider when specifying temperature-controlled packaging. When assessed by packaging type, both active solutions and passive solutions play complementary roles: active solutions, including dry ice systems and refrigerant cartridges, suit shipments requiring sustained low-temperature control or extended transit durations, whereas passive solutions, whether reusable or single-use, often optimize for operational simplicity, lower upfront cost, and lower handling risk on shorter routes.

Temperature range segmentation clarifies selection criteria; chilled temperature options are tailored to many biologics and vaccines that require narrow refrigerated windows, controlled room temperature solutions address many small-molecule formulations where thermal stability is maintained within a defined ambient band, and frozen temperature systems are indispensable for cryogenic or frozen payloads. Insulation material distinctions further inform design choices: expanded polystyrene remains a widely used option for certain single-use applications; phase change materials-encompassing eutectic solutions as well as inorganic and organic formulations-offer engineered thermal buffers for precise hold times; and vacuum insulated panels deliver high performance where space and mass efficiency are paramount. Shipping mode considerations influence packaging robustness and regulatory compliance; air freight, land transport, and sea freight each impose different shock, vibration, and thermal ramp profiles, with land transport subdivided into rail and road choices that affect transit predictability and cold chain continuity. Finally, end-user segmentation demonstrates divergent priorities: clinical research organizations, including both Phase I-II and Phase III-IV facilities, prioritize flexibility and traceability, while distributors, pharmaceutical manufacturers, and pharmacy chains emphasize cost efficiency, handling simplicity, and integration with existing logistics and quality processes.

Regional nuances in infrastructure, regulation, and supply chain maturity shaping divergent adoption patterns and strategic priorities for temperature-controlled packaging across global markets

Regional dynamics shape both the availability of specific technologies and the logistical constraints that influence packaging selection. In the Americas, growing demand for temperature-sensitive therapies and advanced logistics infrastructure favor higher adoption of telemetry-enabled packaging and reusable systems that can be integrated into established cold-chain networks. The emphasis here is on scalability, regulatory compliance, and last-mile reliability as distribution footprints expand.

Across Europe, the Middle East & Africa, regulatory harmonization efforts and sustainability agendas are driving interest in low-carbon solutions and materials with end-of-life recovery pathways. In these markets, a balanced mix of high-performance passive materials and active systems addresses a wide diversity of climatic conditions and transit modalities. The Asia-Pacific region is characterized by rapid biopharma manufacturing growth and fragmented logistics networks, which together increase demand for adaptable packaging solutions capable of supporting long multimodal supply chains. Emerging hubs invest in local manufacturing and material alternatives to reduce cycle time and exposure to cross-border constraints, thereby accelerating adoption of regionally optimized packaging strategies.

How supplier innovation, cross-industry partnerships, and as-a-service commercial models are reshaping competitive dynamics and accelerating integrated temperature-controlled packaging solutions

Competitive and collaborative dynamics among key companies are redefining how packaging solutions are engineered, validated, and brought to market. Leading suppliers are investing in integrated offerings that combine thermal engineering, telemetry, and lifecycle service models to provide turn-key solutions for pharmaceutical customers. This trend favors partnerships between packaging specialists, materials innovators, and logistics providers to ensure seamless end-to-end performance and accountability.

At the same time, innovation pathways include modular product architectures and as-a-service commercial models that reduce capital burden on customers while enabling continuous performance improvement. Strategic collaborations with clinical trial sponsors and contract logistics providers accelerate product qualification cycles, while investments in transparent validation protocols enhance confidence for regulatory submissions. Collectively, these competitive behaviors elevate the role of service, traceability, and sustainability as differentiators in a maturing supplier landscape.

Practical strategic actions for procurement, quality, and logistics leaders to strengthen resilience, lower ownership costs, and align packaging with regulatory and sustainability priorities

Industry leaders can take several pragmatic actions to improve resilience, reduce total cost of ownership, and meet regulatory and sustainability objectives. First, integrate packaging decisions earlier in drug development to align thermal protection requirements with payload sensitivity, dosing formats, and commercial distribution strategies. Early alignment reduces redesign cycles and shortens time to market while ensuring supply chain partners can validate processes ahead of scale-up.

Second, evolve sourcing strategies to incorporate supplier diversification and regional manufacturing where feasible, thereby reducing exposure to tariff volatility and single-source disruptions. Third, adopt modular packaging platforms and telemetry standards to enhance reuse potential and simplify qualification. Fourth, prioritize materials that balance thermal performance with recyclability or reuse potential, and embed life-cycle assessment metrics into procurement evaluations. Finally, strengthen cross-functional governance with clear accountability for packaging performance, excursion remediation, and continuous improvement to ensure operational lessons are rapidly captured and applied across programs.

Methodological overview detailing mixed-methods research combining primary interviews, technical validation, and regulatory synthesis to produce actionable insights for operational decision-makers

The report synthesis draws on a mixed-methods research approach that combines primary interviews, technical validation, and a structured review of publicly available regulatory guidance and standards. Primary inputs include structured interviews with supply chain leaders, packaging engineers, clinical logistics managers, and senior procurement executives, enabling triangulation of practical experiences, pain points, and innovation priorities. These first-hand perspectives inform scenario analysis and the assessment of design tradeoffs across temperature profiles and shipment modalities.

Technical validation involved laboratory performance data provided by manufacturers and independent testing facilities, assessing thermal hold times, impact resistance, and integration of telemetry systems. To ensure contextual accuracy, the research also incorporates a comparative review of regional regulatory frameworks and industry guidance relevant to chain-of-custody, temperature excursion remediation, and packaging validation. This layered methodology supports balanced, actionable findings and recommendations tailored to operational decision-makers.

Concluding perspective emphasizing the strategic imperative of integrating temperature-controlled packaging into end-to-end product lifecycle planning to protect value and ensure continuity

Effective temperature-controlled packaging is now central to pharmaceutical product integrity, regulatory compliance, and commercial delivery. Technological advances in active and passive systems, coupled with more exacting expectations for traceability and sustainability, have elevated packaging as a strategic consideration across development, clinical, and commercial supply chains. Decision-makers must therefore balance thermal performance, operational feasibility, and environmental impact when choosing solutions.

Looking ahead, the intersection of policy shifts, evolving distribution models, and material innovation will continue to reshape supplier selection and sourcing approaches. Organizations that proactively integrate packaging strategy into early development decisions, diversify supply bases to manage geopolitical and tariff risks, and adopt circularity principles where appropriate will be better positioned to preserve product quality while optimizing cost and carbon outcomes. In short, packaging strategy must evolve from transactional procurement to an integral component of product lifecycle management.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceuticals Temperature Controlled Packaging Solutions Market, by Packaging Type

  • 8.1. Active Solutions
    • 8.1.1. Dry Ice Systems
    • 8.1.2. Refrigerant Cartridges
  • 8.2. Passive Solutions
    • 8.2.1. Reusable
    • 8.2.2. Single Use

9. Pharmaceuticals Temperature Controlled Packaging Solutions Market, by Temperature Range

  • 9.1. Chilled Temperature
  • 9.2. Controlled Room Temperature
  • 9.3. Frozen Temperature

10. Pharmaceuticals Temperature Controlled Packaging Solutions Market, by Insulation Material

  • 10.1. Expanded Polystyrene
  • 10.2. Phase Change Materials
    • 10.2.1. Eutectic Solutions
    • 10.2.2. Inorganic
    • 10.2.3. Organic
  • 10.3. Vacuum Insulated Panels

11. Pharmaceuticals Temperature Controlled Packaging Solutions Market, by Shipping Mode

  • 11.1. Air Freight
  • 11.2. Land Transport
    • 11.2.1. Rail Transport
    • 11.2.2. Road Transport
  • 11.3. Sea Freight

12. Pharmaceuticals Temperature Controlled Packaging Solutions Market, by End User

  • 12.1. Clinical Research Organizations
    • 12.1.1. Phase I-II Facilities
    • 12.1.2. Phase III-IV Facilities
  • 12.2. Distributors
  • 12.3. Pharma Manufacturers
  • 12.4. Pharmacy Chains

13. Pharmaceuticals Temperature Controlled Packaging Solutions Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pharmaceuticals Temperature Controlled Packaging Solutions Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pharmaceuticals Temperature Controlled Packaging Solutions Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Pharmaceuticals Temperature Controlled Packaging Solutions Market

17. China Pharmaceuticals Temperature Controlled Packaging Solutions Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Berry Global, Inc.
  • 18.6. Cold Chain Technologies, Inc.
  • 18.7. Cryopak, Inc.
  • 18.8. Envirotainer AB
  • 18.9. Pelican Products, Inc.
  • 18.10. Polar Tech Industries, LLC
  • 18.11. Sealed Air
  • 18.12. Softbox Systems Ltd.
  • 18.13. Sonoco Products Company
  • 18.14. Thermo Fisher Scientific, Inc.
  • 18.15. va-Q-tec AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY DRY ICE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY DRY ICE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY DRY ICE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY REFRIGERANT CARTRIDGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY REFRIGERANT CARTRIDGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY REFRIGERANT CARTRIDGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CHILLED TEMPERATURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CHILLED TEMPERATURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CHILLED TEMPERATURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CONTROLLED ROOM TEMPERATURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY FROZEN TEMPERATURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY FROZEN TEMPERATURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY FROZEN TEMPERATURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY EXPANDED POLYSTYRENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY EXPANDED POLYSTYRENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY EXPANDED POLYSTYRENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY EUTECTIC SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY EUTECTIC SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY EUTECTIC SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INORGANIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INORGANIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INORGANIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ORGANIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ORGANIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ORGANIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY VACUUM INSULATED PANELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY VACUUM INSULATED PANELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY VACUUM INSULATED PANELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY AIR FREIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY AIR FREIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY AIR FREIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY RAIL TRANSPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY RAIL TRANSPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY RAIL TRANSPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ROAD TRANSPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ROAD TRANSPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ROAD TRANSPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SEA FREIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SEA FREIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SEA FREIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE I-II FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE I-II FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE I-II FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE III-IV FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE III-IV FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE III-IV FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHARMA MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHARMA MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHARMA MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHARMACY CHAINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHARMACY CHAINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHARMACY CHAINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 191. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 194. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 195. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 196. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 197. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 198. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 200. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. GCC PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
  • TABLE 224. G7 PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY ACTIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 227. G7 PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PASSIVE SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 228. G7 PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY TEMPERATURE RANGE, 2018-2032 (USD MILLION)
  • TABLE 229. G7 PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY INSULATION MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 230. G7 PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY PHASE CHANGE MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 231. G7 PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY SHIPPING MODE, 2018-2032 (USD MILLION)
  • TABLE 232. G7 PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY LAND TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 233. G7 PHARMACEUTICALS TEMPERATURE CONTROLLED PACKAGING SOLUTIONS MARKET SIZE, BY END USER, 2018-